acipimox trade name olbetam europe niacin derivative used lipidlowering agent reduces triglyceride levels increases hdl cholesterol may less marked adverse effects niacin although unclear whether recommended dose effective standard doses niacin contraindications peptic ulcers acute bleeding recent heart attack acute decompensated heart failure severe chronic kidney niacin related drugs common adverse effects flushing associated prostaglandin gastrointestinal disturbances indigestion occur least flushing reduced taking aspirin minutes taking acipimox palpitations also describedcitation needed high doses cause precipitate goutcitation needed contrast niacin impairment glucose tolerance disorders liver function found studies even high doses interactions drugs known theoretically combination statins fibrates could increase incidence myalgia alcohol increase risk like niacin acipimox acts niacin receptor inhibiting enzyme triglyceride lipase reduces concentration fatty acids blood plasma inflow liver consequently vldl cholesterol production liver reduced leads indirectly reduction ldl increase hdl acipimox completely absorbed gut bound blood plasma proteins metabolized elimination occurs two phases first halflife two hours second hours substance eliminated via httpsenwikipediaorgwikiacipimox